financetom
Technology
financetom
/
Technology
/
Gold price forecast update 28-10-2024
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gold price forecast update 28-10-2024
Oct 28, 2024 7:31 AM

Gold price trades negatively now, affected by stochastic current negativity, which supports the chances of resuming the expected correctional bearish trend for today, which its targets begin by breaking 2722.00$ to open the way to head towards 2700.00$.

Therefore, we will continue to suggest the bearish trend for today unless breaching 2747.00$ and holding above it.

The expected trading range for today is between 2710.00$ support and 2747.00$ resistance.

Trend forecast: Bearish

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trio-Tech Delivers Q4 Revenue Growth and Profitability and Strengthens Balance Sheet
Trio-Tech Delivers Q4 Revenue Growth and Profitability and Strengthens Balance Sheet
Sep 21, 2025
VAN NUYS, Calif.--(BUSINESS WIRE)-- Trio-Tech International ( TRT ) , a comprehensive provider of semiconductor back-end solutions and a global value-added supplier of electronic equipment, today announced its financial results for the fourth quarter and full year ended June 30, 2025. Trio-Tech International ( TRT ) Chairman and CEO S.W. Yong’s Comments: “In the fourth quarter, Trio-Tech achieved year-over-year revenue...
TECVAYLI® and DARZALEX FASPRO®-based induction treatment demonstrates promising rates and depths of response in transplant-eligible patients with newly diagnosed multiple myeloma
TECVAYLI® and DARZALEX FASPRO®-based induction treatment demonstrates promising rates and depths of response in transplant-eligible patients with newly diagnosed multiple myeloma
Sep 21, 2025
100 percent of evaluable patients achieved minimal residual disease (MRD) negativity following induction therapy in updated results from the Phase 2 MajesTEC-5 study TORONTO, Sept. 19, 2025 /PRNewswire/ -- Johnson & Johnson ( JNJ ) today announced that an investigational immune-based induction regimen with TECVAYLI® (teclistamab-cqyv) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) demonstrated meaningful clinical efficacy in transplant-eligible (TE) patients...
Jumpstart Agent to Exhibit at Dreamforce 2025
Jumpstart Agent to Exhibit at Dreamforce 2025
Sep 21, 2025
SAN FRANCISCO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Jumpstart Agent, a Salesforce Partner and the AI-powered platform that gets small and midsize businesses live in under a week, announced it will attend Dreamforce 2025 in San Francisco. This year, Jumpstart Agent will show that the future of CRM starts on day one by demonstrating its onboarding solution at Booth #302....
Silicon Valley Gen AI Inference Compute Provider Tensordyne Achieves IDCA G2 Certification
Silicon Valley Gen AI Inference Compute Provider Tensordyne Achieves IDCA G2 Certification
Sep 21, 2025
SUNNYVALE, Calif., Sept. 19, 2025 /PRNewswire/ -- International Data Center Authority (IDCA) reports that Tensordyne has been able to achieve the G2 certification level after successfully completing the SDS (System, Design, Service) evaluation process for its enterprise AI platform. We are extremely proud of this accomplishment and becoming G2 certified by IDCA, validating the fact that we are making AI available...
Copyright 2023-2026 - www.financetom.com All Rights Reserved